SGMT Financials
Sagimet Biosciences Inc. Series A Common Stock - Financial statements & key metrics
Stock Price
$10.57
Market Cap
$403.24M
P/E Ratio
-4.0
EPS
$-2.66
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-45.57M
EPS (Diluted)
$-1.45
Balance Sheet Highlights
Total Assets
$160.26M
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
$75.84M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-42.44M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-1393.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is SGMT revenue?
View SGMT's income statement for detailed revenue data.
Is SGMT profitable?
SGMT reported a loss of $45.57M in the most recent quarter. The net profit margin is -1393.8%.
What is SGMT market cap?
SGMT has a market capitalization of $403.24M, making it a small-cap stock.
Does SGMT have debt?
View SGMT's balance sheet for debt information.
What is SGMT cash flow?
Cash flow data is available in the full financial statements.